Skip to content

Drug interactions

Brexpiprazole + Larotrectinib

Severity: Minor

Brexpiprazole and Larotrectinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a weak CYP3A4 inhibitor and might slightly increase brexpiprazole exposure. A clinically meaningful effect is not expected.

What this interaction means in plain words

Brexpiprazole and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Brexpiprazole belongs to Central Nervous System; Larotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Weak inhibition of CYP3A4 by larotrectinib may modestly reduce brexpiprazole metabolism.

What to do

No dose adjustment is needed; watch for sedation or akathisia and adjust the dose if they occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brexpiprazole and Larotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brexpiprazole with Larotrectinib?

MediHelp rates the interaction as minor. Brexpiprazole and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a weak CYP3A4 inhibitor and might slightly increase brexpiprazole exposure. A clinically meaningful effect is not expected.

How serious is the interaction between Brexpiprazole and Larotrectinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed; watch for sedation or akathisia and adjust the dose if they occur.

What other medicines interact with Brexpiprazole?

MediHelp also lists interactions of Brexpiprazole with, for example, Alfentanil, Amisulpride, Apalutamide. The full list is on the Brexpiprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in